PapiVax Biotech, Inc. Report issue

For profit Phase 1 Phase 2
Founded: Saverna Park MD United States (2010)

Organization Overview

First Clinical Trial
2019
NCT03911076
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

PapiVax Biotech, Inc.